Average Co-Inventor Count = 3.47
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nsgene A/s (11 from 19 patents)
2. Biogen Idec Ma Inc. (4 from 216 patents)
3. Hoba Therapeutics Aps (4 from 4 patents)
4. Nsgenee A/s (1 from 1 patent)
16 patents:
1. 10034918 - Therapeutic use of a growth factor, METRNL
2. 9861682 - Treatment of hyperalgesia, spontaneous pain, and phantom pain
3. 9845344 - Therapeutic use of a growth factor, NsG33
4. 9675669 - Therapeutic use of a growth factor, METRNL
5. 9474786 - Treatment of allodynia
6. 9314502 - Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
7. 9068015 - Therapeutic use of a growth factor, METRNL
8. 8815810 - Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
9. 8404642 - Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
10. 8334264 - Therapeutic use of a growth factor, METRNL
11. 8217146 - Neurotrophic factors and methods of use thereof
12. 7655463 - Methods of activating RET receptor tyrosine kinase using neurotrophic factors
13. 7358228 - Methods of treating pain using neurotrophic factors
14. 7276580 - Neurotrophic factors
15. 6734284 - Neublastin neurotrophic factors